Amino acid transport systems in the human hepatoma cell line Hep G2.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 1333197)

Published in Biochem Biophys Res Commun on November 30, 1992

Authors

S Goenner1, A Boutron, T Soni, A Lemonnier, N Moatti

Author Affiliations

1: Laboratoire Central de Biochimie, Hôpital de Bicêtre, France.

Articles by these authors

Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit Care Med (2001) 2.26

Imipenem/vancomycin for Rhodococcus equi pulmonary infection in HIV-positive patient. Lancet (1991) 1.66

Monoclonal and oligoclonal gammopathies in heart-transplant recipients. Clin Chem (1991) 1.54

Simultaneous determination of serum neopterin and C-reactive protein as markers of infection in heart-transplant recipients. Clin Chem (1989) 1.52

HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol (1997) 1.51

Impaired mitochondrial pyruvate importation in a patient and a fetus at risk. Mol Genet Metab (2003) 1.28

Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta (1982) 1.24

Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus. Clin Chem Lab Med (1999) 1.24

A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb (1994) 1.19

Improved fluorometric determination of malonaldehyde. Clin Chem (1991) 1.15

Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein. Mol Genet Metab (2011) 1.10

Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant (2001) 1.08

Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol (1998) 1.07

Study of minimal inhibitory concentration of antibiotics on bacteria cultivated in vitro in space (Cytos 2 experiment). Aviat Space Environ Med (1985) 1.07

Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J Lipid Res (1996) 1.04

Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem (1984) 1.03

[In vitro activity of twenty antibiotics against Rhodococcus equi]. Pathol Biol (Paris) (1991) 1.01

Antibiotic activity in space. Drugs Exp Clin Res (1986) 0.99

Effect of lactation in a mother with galactosemia. J Pediatr (1989) 0.98

Prolidase and prolidase deficiency. Life Sci (1984) 0.97

Normal serum gamma-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J Pediatr (1987) 0.94

Oxidative modifications of low-density lipoproteins (LDL) by the human endothelial cell line EA.hy 926. Experientia (1996) 0.92

Two silent substitutions in the PDHA1 gene cause exon 5 skipping by disruption of a putative exonic splicing enhancer. Mol Genet Metab (2007) 0.92

Diagnostic value of serum gamma-glutamyl transpeptidase activity in liver diseases in children. J Pediatr Gastroenterol Nutr (1991) 0.92

Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI. J Clin Invest (1995) 0.90

Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic men. The PCV METRA Group. Circulation (1992) 0.89

Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol (2000) 0.88

Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat. Br J Exp Pathol (1987) 0.88

Retrospective diagnosis of carnitine-acylcarnitine translocase deficiency by acylcarnitine analysis in the proband Guthrie card and enzymatic studies in the parents. J Inherit Metab Dis (1996) 0.88

Defects in activation and transport of fatty acids. J Inherit Metab Dis (1999) 0.87

Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis (2001) 0.87

[Application of derivative spectrophotometry in biochemistry]. Ann Biol Clin (Paris) (1985) 0.87

Determination of dipeptides in urine. Clin Chim Acta (1974) 0.86

Preliminary results of the "Antibio" experiment. Naturwissenschaften (1986) 0.86

Behavior of bacteria and antibiotics under space conditions. Aviat Space Environ Med (1994) 0.86

Growth and division of Escherichia coli under microgravity conditions. Res Microbiol (1994) 0.86

Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes. Ann Clin Biochem (1995) 0.86

A new DNA polymorphism in the 5' untranslated region of the human SREBP-1a is related to development of atherosclerosis in high cardiovascular risk population. Atherosclerosis (2001) 0.85

A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler Thromb Vasc Biol (1996) 0.85

A method to screen for the antioxidant effect of compounds on low-density lipoprotein (LDL): illustration with flavonoids. J Pharmacol Toxicol Methods (1993) 0.84

Thiamine responsive pyruvate dehydrogenase deficiency in an adult with peripheral neuropathy and optic neuropathy. J Neurol Neurosurg Psychiatry (2008) 0.84

[Lipoprotein lipase activity in human milk; inhibition in vitro of the glucuro-conjugation of bilirubin (author's transl)]. Clin Chim Acta (1975) 0.84

Faster estimation of reserve bilirubin binding capacity of serum from the neonate by thin-layer chromatography on sephadex. Clin Chem (1977) 0.83

Lipid peroxidation abnormalities in hemodialyzed patients. Nephron (1993) 0.83

Isolation and characterization of an abnormal alpha slow-moving high-density lipoprotein subfraction in serum from children with long-standing cholestasis. Clin Chem (1986) 0.82

Abnormalities of lipid metabolism and arterial rigidity in young subjects with borderline hypertension. Clin Invest Med (1994) 0.82

Defective galactose oxidation in a patient with glycogen storage disease and Fanconi syndrome. Pediatr Res (1983) 0.82

Cell density affects prolidase and prolinase activity and intracellular amino acid levels in cultured human cells. Clin Chim Acta (1985) 0.82

Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men. PCVMETRA Group. Arterioscler Thromb (1994) 0.82

[The intermittent variant of leucinosis (study of a new case)]. Arch Fr Pediatr (1971) 0.82

Preliminary results of Cytos 2 experiment. Acta Astronaut (1985) 0.82

Plasma prolidase and prolinase activity in alcoholic liver disease. Clin Chim Acta (1988) 0.82

Lens hexitols and cataract formation during lactation in a woman heterozygote for galactosaemia. J Inherit Metab Dis (1989) 0.81

Fatty acid composition of an oral load affects chylomicron size in human subjects. Br J Nutr (1997) 0.81

Homocysteine decreases endothelin-1 production by cultured human endothelial cells. Eur J Biochem (1999) 0.81

Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem (1991) 0.81

Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography. J Lipid Res (1991) 0.81

Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron (1991) 0.81

[Hepatic glycogenoses. Introduction]. Ann Gastroenterol Hepatol (Paris) (1988) 0.81

[Biological and physiopathological aspects of hepatic glycogenoses]. Ann Gastroenterol Hepatol (Paris) (1988) 0.80

Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol (1999) 0.80

Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transplant (1998) 0.80

[Study of the metabolism of tryptophane in various hepato-intestinal diseases. II. Frequency of anomalies in neoplastic diseases]. Rev Fr Etud Clin Biol (1967) 0.80

High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells. Biochem J (1996) 0.79

Transport of L-histidine by human diploid fibroblasts in culture. In Vitro (1983) 0.79

Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis. J Inherit Metab Dis (1994) 0.79

[Effect of cycloleucine on renal uptake of dibasic amino acids and cystine]. Biomedicine (1976) 0.79

Charge heterogeneity of LDL in asymptomatic hypercholesterolemic men is related to lipid parameters and variations in the ApoB and CIII genes. Arterioscler Thromb Vasc Biol (1998) 0.79

Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI. J Inherit Metab Dis (1988) 0.79

Structural changes of high-density-lipoprotein apolipoproteins following incubation with human polymorphonuclear cells. Eur J Biochem (1994) 0.79

Effects of alpha-tocopherol on antioxidant enzyme activity in human fibroblast cultures. Int J Vitam Nutr Res (1993) 0.79

[Value of derivative spectrophotometry for the determination of plasma and urinary hemoglobin. Comparison with the method using Allen's correction]. Ann Biol Clin (Paris) (1986) 0.79

Metabolic effects of galactose on human HepG2 hepatoblastoma cells. Metabolism (1994) 0.79

Respective effects of glucose and glutamine on the glutamine synthetase activity of human skin fibroblasts. Mol Cell Biochem (1991) 0.78

Influence of two cell harvesting methods on intracellular ATP and amino acid concentrations in human fibroblast cultures. Biochimie (1983) 0.78

Tyrosine aminotransferase isoenzyme deficiency. J Pediatr (1979) 0.78

Effect of cycloleucine on amino acid accumulation by human diploid fibroblasts. Clin Chim Acta (1978) 0.78

[Lipoprotein anomalies in HIV infections]. Ann Med Interne (Paris) (1996) 0.78

Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin. Ann Biol Clin (Paris) (1989) 0.78

Characteristics of ten charge-differing subfractions isolated from human native low-density lipoproteins (LDL). No evidence of peroxidative modifications. Biochim Biophys Acta (1995) 0.78

BiP expression is not increased by the accumulation of PiZ alpha 1-antitrypsin in the endoplasmic reticulum. FEBS Lett (1990) 0.78

A simple radioactivity assay for measurement of methionine adenosyltransferase activity by aqueous chromatography. Clin Chim Acta (1983) 0.78

Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity. Gastroenterology (1996) 0.78

[Modification of aminoaciduria in the rat after administration of cycloleucine: comparison with human cystinuria]. Clin Chim Acta (1971) 0.78

Some metabolic differences between human skin and aponeurosis fibroblasts in culture. J Cell Physiol (1980) 0.78

Transport of L-alanine in cultured human fibroblasts: evidence for two kinetically distinguishable systems. J Cell Physiol (1981) 0.78